Showing 1,521 - 1,540 results of 109,543 for search '(( a point decrease ) OR ( 5 ((((teer decrease) OR (we decrease))) OR (a decrease)) ))', query time: 1.43s Refine Results
  1. 1521

    Exercise testing criteria to diagnose lower extremity peripheral artery disease assessed by computed-tomography angiography by O. Stivalet (6890189)

    Published 2019
    “…The receiver-operating-characteristic curve was used to define a cut-off point corresponding to the best area under the curve (AUC; [CI95%]) to detect arterial stenosis ≥50% as determined by the CTA.…”
  2. 1522
  3. 1523
  4. 1524
  5. 1525

    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

    Published 2025
    “…After exposure to F-53B at 2, 10, and 50 ng/L, C. elegans showed an aging phenomenon as lipofuscin was significantly increased by 48.7–57.5% and locomotion, such as center point speed, was significantly decreased in all exposure groups. …”
  6. 1526

    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

    Published 2025
    “…After exposure to F-53B at 2, 10, and 50 ng/L, C. elegans showed an aging phenomenon as lipofuscin was significantly increased by 48.7–57.5% and locomotion, such as center point speed, was significantly decreased in all exposure groups. …”
  7. 1527

    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

    Published 2025
    “…After exposure to F-53B at 2, 10, and 50 ng/L, C. elegans showed an aging phenomenon as lipofuscin was significantly increased by 48.7–57.5% and locomotion, such as center point speed, was significantly decreased in all exposure groups. …”
  8. 1528

    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

    Published 2025
    “…After exposure to F-53B at 2, 10, and 50 ng/L, C. elegans showed an aging phenomenon as lipofuscin was significantly increased by 48.7–57.5% and locomotion, such as center point speed, was significantly decreased in all exposure groups. …”
  9. 1529
  10. 1530

    Strains used in this study. by Xin Zhou (54275)

    Published 2024
    “…Here, we found that the ergosterol biosynthesis gene <i>ERG251</i> is a hotspot for point mutations during adaptation to antifungal drug stress within two distinct genetic backgrounds of <i>Candida albicans</i>. …”
  11. 1531

    Primers used in this study. by Xin Zhou (54275)

    Published 2024
    “…Here, we found that the ergosterol biosynthesis gene <i>ERG251</i> is a hotspot for point mutations during adaptation to antifungal drug stress within two distinct genetic backgrounds of <i>Candida albicans</i>. …”
  12. 1532

    <i>ERG251</i> SNPs from all FLC-evolved strains. by Xin Zhou (54275)

    Published 2024
    “…Here, we found that the ergosterol biosynthesis gene <i>ERG251</i> is a hotspot for point mutations during adaptation to antifungal drug stress within two distinct genetic backgrounds of <i>Candida albicans</i>. …”
  13. 1533
  14. 1534
  15. 1535
  16. 1536
  17. 1537
  18. 1538
  19. 1539
  20. 1540

    Data extraction grid. by Heloisa Ricci Conesa (18291210)

    Published 2024
    “…No homogenous trends were identified in incidence rates across countries, or in detection of S. pneumoniae as a cause of AOM over time. There were indications of a reduction in hospitalization rates (decreases between 24.5–38.8% points, depending on country, PCV type and time since PCV introduction) and antibiotic resistance (decreases between 14–24%, depending on country), following the widespread use of PCVs over time. …”